Postdoctoral Scientist - Neuropsychiatry

At Lilly, the work is demanding because patients are waiting. We unite caring with discovery to help make life better for people around the world, knowing that every decision, every detail, and every day matters. Headquartered in Indianapolis, Indiana, our over 50,000 employees around the globe take on complex challenges to discover and deliver life-changing medicines, strengthen how health is understood and managed, and support the communities we serve.

This is hard, urgent, selfless work-but it's work worth doing. If you're driven by purpose and ready to bring your best to work that truly matters for patients, we invite you to join us.

Are you looking to make a significant difference by advancing our understanding of psychiatric diseases such as schizophrenia and major depressive disorder? If so, this might be the right role for you. We are seeking an ambitious postdoctoral scientist with strong research and communication skills to contribute to a high-visibility research program at the intersection of human iPSC biology, neuroscience, and functional genomics.

Your work will contribute to establishing a cutting-edge human iPSC-derived co-culture platform to study neuron-astrocyte interactions in psychiatric conditions - a powerful approach to uncovering disease mechanisms and identifying novel therapeutic targets. In this role, you will:

+ Develop and characterize human iPSC-derived tri- and quad-culture models containing excitatory neurons, inhibitory neurons, astrocytes, and potentially microglia to study neuron-glia interactions in psychiatry-relevant contexts.

+ Apply multielectrode array (MEA) electrophysiology and automated patch-clamp (autopatcher) to assess network dynamics and single-cell excitability in iPSC co-culture models.

+ Utilize mRNA lipid nanoparticle (LNP) delivery for transient gene over-expression and perturbation (including CRISPR knockout/interference) in iPSC cultures - a novel approach in this field.

+ Investigate functional consequences of psychiatric risk gene variants on astrocyte function and neuron-astrocyte signaling.

+ Perform single-cell or single-nucleus RNA-Seq from co-culture models and apply pathway analysis to identify disease-associated gene modules and hub genes.

+ Integrate multi-modal datasets (electrophysiological, morphological, transcriptomic) to establish mechanistic links between genetic perturbations and neuronal network dysfunction.

+ Design and execute rescue experiments using pharmacological and genetic strategies to validate therapeutic hypotheses.

+ Collaborate with cross-functional teams including computational biology, bioinformatics, medicinal chemistry, and external academic partners.

+ Present findings at major scientific conferences (e.g., Society for Neuroscience, ACNP) and publish in high-impact peer-reviewed journals as first author.

+ Maintain external awareness and learning to benefit the organization. Identify areas of key need to champion creative solutions.

** Basic Qualifications*
* + PhD in Neuroscience, Cell Biology, Molecular Biology, or a closely related field.

+ Demonstrated experience with at least one of the following: human iPSC culture and directed differentiation, primary neuronal culture, electrophysiology (patch-clamp or MEA), or neuron-glia biology.

+ Strong publication record demonstrating scientific productivity and independence.

+ Qualified applicants must be authorized to work in the United States on a full-time basis. Lilly will not provide support for or sponsor work authorization or visas for this role, including but not limited to F-1 CPT, F-1 OPT, F-1 STEM OPT, J-1, H-1B, TN, O-1, E-3, H-1B1, or L-1.

** Additional Information*
* + This position is not permanent and requires US citizenship or permanent resident status. It is for a fixed duration of two years with potential to extend to three years and for a maximum of up to four years. You will have opportunities to apply for full-time positions after your duration is complete.

+ Lilly is an EEO/Affirmative Action Employer and does not discriminate on the basis of age, race, color, religion, gender, sexual orientation, gender identity, gender expression, national…